Liptruzet Side Effects
Generic Name: atorvastatin / ezetimibe
Note: This document contains side effect information about atorvastatin / ezetimibe. Some of the dosage forms listed on this page may not apply to the brand name Liptruzet.
The more commonly reported adverse reactions have included increased ALT, increased AST, and musculoskeletal pain.[Ref]
Common (1% to 10%): ALT increased (5%), AST increased (4%)
Common (1% to 10%): Musculoskeletal pain (3.8 to 4%), arthralgia (3 to 6.9%), pain in extremity (2.7 to 6%), myalgia (3.5%), muscle spasms (3%), muscle weakness (2%)
Postmarketing reports: Myopathy/rhabdomyolysis, necrotizing myopathy (rarely), injury, poisoning and procedural complication, tendon rupture, myositis[Ref]
Common (1% to 10%): Hot flushes (2%)[Ref]
Common (1% to 10%): Urinary tract infection (5.7%)[Ref]
Common (1% to 10%): Coughing (2 to 3%), bronchitis (2%), sinusitis (2 to 2.8%), upper respiratory tract infection (4.3%), nasopharyngitis (up to 8.3%), pharyngolaryngeal pain (up to 2.3%)
Postmarketing reports: Interstitial lung disease[Ref]
Postmarketing reports: Fatigue
1. Cerner Multum, Inc. "Australian Product Information." O 0
2. "Product Information. Liptruzet (atorvastatin-ezetimibe)." Merck & Company Inc, Whitehouse Station, NJ.
More about Liptruzet (atorvastatin / ezetimibe)
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Drug class: antihyperlipidemic combinations
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.